Relief Therapeutics Holding AG (0QKQ.L)

CHF 4.05

(-8.58%)

Net Income Summary of Relief Therapeutics Holding AG

  • Relief Therapeutics Holding AG's latest annual net income in 2023 was -98.18 Million CHF , down -93.31% from previous year.
  • Relief Therapeutics Holding AG's latest quarterly net income in 2024 Q2 was -4.55 Million CHF , down 0.0% from previous quarter.
  • Relief Therapeutics Holding AG reported an annual net income of -50.79 Million CHF in 2022, down -46.35% from previous year.
  • Relief Therapeutics Holding AG reported an annual net income of -34.7 Million CHF in 2021, down -343.34% from previous year.
  • Relief Therapeutics Holding AG reported a quarterly net income of -98.18 Million CHF for 2023 FY, down -93.31% from previous quarter.
  • Relief Therapeutics Holding AG reported a quarterly net income of -41.68 Million CHF for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Relief Therapeutics Holding AG (2023 - 2007)

Historical Annual Net Income of Relief Therapeutics Holding AG (2023 - 2007)

Year Net Income Net Income Growth
2023 -98.18 Million CHF -93.31%
2022 -50.79 Million CHF -46.35%
2021 -34.7 Million CHF -343.34%
2020 -7.82 Million CHF -4.93%
2019 -7.46 Million CHF -1611.01%
2018 -436 Thousand CHF 84.9%
2017 -2.88 Million CHF 82.85%
2016 -16.83 Million CHF -83.89%
2015 -9.15 Million CHF 25.46%
2014 -12.28 Million CHF -0.89%
2013 -12.17 Million CHF -87.69%
2012 -6.48 Million CHF 89.04%
2011 -59.16 Million CHF -205.03%
2010 -19.39 Million CHF -58.81%
2009 -12.21 Million CHF -29.92%
2008 -9.4 Million CHF -369.97%
2007 -2 Million CHF 0.0%

Peer Net Income Comparison of Relief Therapeutics Holding AG

Name Net Income Net Income Difference
Tecan Group AG 132.07 Million CHF 174.337%
Santhera Pharmaceuticals Holding AG 54.78 Million CHF 279.221%
Basilea Pharmaceutica AG 10.45 Million CHF 1039.441%
Bachem Holding AG 111.85 Million CHF 187.772%
Siegfried Holding AG 112.77 Million CHF 187.06%
Molecular Partners AG -61.98 Million CHF -58.397%